Skip to main content
Erschienen in: BMC Oral Health 1/2022

Open Access 01.12.2022 | Research

Evaluation of the antibacterial activity of Lactobacilli probiotics supernatants against Enterococcus faecalis (in-vitro study)

verfasst von: Shymaa Shaaban, Gamal M. Hamad, Salma Genena, Marwa A. Meheissen, Sybel Moussa

Erschienen in: BMC Oral Health | Ausgabe 1/2022

Abstract

Background

There is an increasing demand to find a potent antibacterial agent against endodontic pathogens with the least toxic effect. The study aimed to evaluate the antibacterial activity of Lactobacilli probiotics on Enterococcus faecalis (E. faecalis) in comparison to calcium hydroxide paste.

Methods

The study involved two stages; (stage one): determination of the antibacterial properties of three strains of Lactobacilli probiotics supernatants (PS); Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, and a cocktail mix of the three supernatants against E. faecalis using agar well diffusion method in both solution and gel phase. The formed zones of inhibition (ZOI) were measured in millimeters (mm) and compared to each other. PS solution and gel of the largest ZOI were further compared with calcium hydroxide paste (35% Ultra Cal XS Ca(OH)2) This was followed by (stage two): assessment of the minimum inhibitory concentration (MIC) of the PS that showed the largest ZOI against E. faecalis by agar well diffusion assay for both PS solution and gel.

Results

All supernatants showed growth inhibition against E. faecalis, and the cocktail mix showed the largest ZOI. However, no significant difference was found between the supernatants in both the solution and gel phases (p > 0.05). Ca(OH)2 showed a significantly lower effect than both the cocktail mix solution and gel (p < 0.05). The MIC of the cocktail mix solution and gel against E. faecalis was 50 mg/ml. (p > 0.05).

Conclusion

PS has an antibacterial effect on E. faecalis and was more effective than Ca(OH)2. Lactobacilli probiotics could be a promising antibacterial agent used as an irrigant or an intracanal medication.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
E. faecalis
Enterococcus faecalis
Ca(OH)2
Calcium hydroxide
WHO
The World Health Organization
GRAS
Generally recognized as safe
PRILE
Preferred reporting items for laboratory studies in endodontology
MRS
DeMan rosa sharpe
CFS
Cell-free supernatant
PS
Probiotics supernatants
LP
Lactobacillus plantarum
LR
Lactobacillus rhamnosus
LA
Lactobacillus acidophilus
ZOI
Zone of inhibition
MIC
Minimum inhibitory concentration
BMD
Broth microdilution
CLSI
Clinical Laboratory Standards Institute
CAMHB
Cation-adjusted Mueller–Hinton broth

Background

Failure of endodontic therapy is attributed to the survival of microorganisms in the root-filled teeth [13]. Removing all the intra-radicular bacteria is impossible because of the complex anatomy of the root canal system, including accessory canals, isthmus, and apical ramification, which almost limit the effect of mechanical preparation and chemicals used in the main canal [4, 5].
Enterococcus faecalis (E. faecalis) is one of the most commonly isolated bacteria from failed root canal treatments because of its virulence factors [1, 6, 7]. E. faecalis is a gram-positive facultative anaerobe with high survival mechanisms [68]. It forms a resistant biofilm that deeply invades the dentinal tubules and can adapt to extreme environmental conditions withstanding long periods of low nutrition [8, 9]. The presence of a proton pump is considered the primary resistance mechanism of E. faecalis to many intra-canal medicaments and irrigants [9, 10].
Calcium hydroxide (Ca(OH)2) is the most widely used intracanal medication in endodontics owing to its antimicrobial effect [11]. Its high alkalinity produced by the release of hydroxyl ions is responsible for destroying the bacterial cell membrane, DNA, and protein structure [1113]. Despite its advantages, E. faecalis is resistant to the high pH of Ca(OH)2 [9, 13].
Probiotics are living microorganisms, mainly bacteria, that provide beneficial health effects to individuals and are widely used in dietary products [14, 15]. The World Health Organization (WHO) defined probiotics as “live microorganisms which, when administered in adequate amounts in food or as dietary supplement confer a health benefit on the host” [16]. The most commonly used strains of probiotics are lactobacilli (lactic acid) bacteria and bifidobacteria [15, 17].
The era of biological medications is not new since live microorganisms (probiotics) were successfully used in controlling gastrointestinal diseases, including infantile diarrhea, necrotizing enterocolitis, antibiotic-associated diarrhea, Rotavirus diarrhea, Helicobacter pylori infections as well as traveler's diarrhea [18, 19]. They have been used to inhibit Clostridium perfringens poultry meat infection and control food contamination and aflatoxin production [20, 21].
Probiotics have been previously used for treatment of oral health diseases [22]. They were used in caries control management [23, 24], treatment of halitosis, and oral candidiasis [25, 26] and have shown reasonable results when used as an adjunctive treatment for periodontitis [2729]. However, their application in endodontic treatment still needs validation [30]. Hammad’s study in 2013 did not show an inhibitory effect of probiotics against E. faecalis [31], while other recent studies stated that probiotics were effective against endodontic pathogens [3237]. Supplementation with probiotics significantly reduced inflammation and bone resorption in rats with apical periodontitis, suggesting their possible role in reducing the severity of apical periodontitis [38, 39]. Consequently, probiotics can be used as irrigants, intracanal medications, or even in regenerative endodontics because of their antibacterial and anti-inflammatory properties [15, 32, 35].
Lactobacillus strains are the most typical species of probiotics as they are desirable members of the intestinal microflora and have been “Generally Recognized As Safe” (GRAS) status [20, 40]. The strong antagonistic effects of Lactobacillus against a wide range of human pathogens make it a potential regimen for treatment and prevention of infections [40, 41].
With the limitation of Ca(OH)2 use against E. faecalis and the demand for a new medication to eradicate all bacteria inside the root canal system; the study aimed to assess and compare the antibacterial effect of Lactobacilli probiotics medication and Ca(OH)2 paste against E. faecalis.
The null hypothesis of the current study was that there would be no difference in the antibacterial effect of Lactobacilli probiotics in solution and gel forms against E. faecalis compared to Ca(OH)2 paste.

Methods

Study design

The manuscript of this laboratory study has been written according to Preferred Reporting Items for Laboratory studies in Endodontology (PRILE) 2021 guidelines [42]. (Fig. 1).
All tests were done in duplicates, and data were collected by two calibrated observers and presented as mean and standard deviation.

Probiotics culture and supernatant preparation

Three strains of Lactobacilli Probiotics (Lactobacillus plantarum ATCC 14,917, Lactobacillus rhamnosus ATCC 7469, and Lactobacillus acidophilus ATCC 4356) were obtained from Microbiological Resources Centre (MIRCEN), Faculty of Agriculture, Ain Shams University, Cairo, Egypt. They were grown individually on De Man, Rogosa, and Sharpe (MRS) broth (HiMedia Laboratories Pvt. Ltd, India) aerobically for 48 h at 37 °C. The concentration of bacteria was OD600 = 0.6 for each strain. The pure isolate of Lactobacilli species suspension was propagated in a 100 ml flask containing MRS broth and incubated for 72 h at 37 °C. The cell-free supernatant (CFS) was obtained by centrifuging the culture at 10,000 rpm for 10 min and sterilized by syringe filter size 0.45 micron,, then lyophilized using a vacuum freeze dryer (Model FDF 0350, Korea) [20, 21].

Poloxamer gel preparation

Poloxamer 407 powder was purchased from Sigma Aldrich Chemical Co., Gillingham, UK. Poloxamer gel was prepared using the 'cold technique’ by adding poloxamer 407 powder gradually to cold water (4–8 °C) under magnetic stirring up to a final concentration of 30% (w/w) poloxamer and kept in the refrigerator overnight to be ready for use [4345].
This study was conducted on two stages under a sterile aseptic condition in a biosafety cabinet (Class II, Thermo scientific microbiological safety cabinet, Germany):

Stage 1: assessment of antibacterial activity of probiotics supernatants (PS) in liquid and gel phase against E. faecalis then compare it with Ca(OH)2 paste

PS solution
The lyophilized CFS of each of the three supernatants was mixed individually with sterile water to obtain PS solution of 200 mg/ml concentration. Also, a cocktail mix of the three supernatants was further obtained by combining equal volume of each CFS (200 mg/ml). The antibacterial activity of the three prepared PS, and the cocktail mix (Lactobacillus plantarum (LP), Lactobacillus rhamnosus (LR) and Lactobacillus acidophilus (LA)) were tested for their antibacterial effect against E. faecalis using agar well diffusion method [20, 33].
E. faecalis (ATCC 29,212) (American Type Culture Collection, Manassas, Virginia, USA.) was chosen for this study as an example of an endodontic pathogen and grown on a blood agar (HiMedia Laboratories Pvt. Ltd, India) plate at 37 °C for 24 h. A bacterial suspension of E. faecalis was prepared and adjusted to half MacFarland standard (1.5 × 108 CFU/ml) using DEN-1, MacFarland densitometer (biosan, SIA, Latvia).
An agar plate was seeded with the prepared bacterial culture suspension of E. faecalis using a sterile cotton swab. Five wells were made on the agar plate using a cork borer of size 6 mm, four experimental wells and one control. The supernatants were loaded to each separate well (200 μl) as follows; 1: LP, 2:LR, 3: LA, 4: cocktail mix and, 5: sterile water (control) then incubated at 37 °C /24 h in an incubator (BINDER, Tuttlingen, Germany) [21].
PS gel
The lyophilized CFS of each of the three supernatants was mixed individually with poloxamer gel to get PS gel at 200 mg/ml concentration. A cocktail mix gel of the three supernatants was obtained at the same concentration.
The antibacterial activity of PS gel was also tested against E. faecalis in another agar plate using agar well diffusion assay as previously mentioned, four experimental wells and one control. The wells were loaded as follows; 1: LP (PS) gel, 2:LR (PS) gel, 3: LA (PS) gel, 4: cocktail mix gel and, 5: poloxamer gel (control) and incubated at 37 °C /24 h in an incubator (BINDER, Tuttlingen, Germany) [21].
For both plates, the formed zone of inhibition (ZOI) was recorded by two calibrated observers, measured in millimeters (mm), and compared to evaluate the antibacterial potential of each supernatant. The largest ZOI would indicate the most efficient PS in both gel and solution phases that would be further tested for the minimum inhibitory concentration (MIC) [21, 33].
Comparison of the antibacterial activity of PS solution, gel, and Ca(OH)2 paste against E. faecalis
The PS that showed the largest ZOI in solution and gel forms were compared to Ca(OH)2 paste (Ultra Cal XS Ca(OH)2) (Ultra dent Products Inc., South Jordan, UT, USA.).
An agar plate was seeded with a bacterial culture of E. faecalis using a sterile cotton swab. Three wells were made on the agar plate by using a cork borer of size 6 mm, one well was loaded with PS solution, the second was loaded with PS gel, and the last was loaded with Ca(OH)2 paste (35% Ultra Cal XS Ca(OH)2).
The plate was then incubated at 37 °C/24 h in an incubator (BINDER, Tuttlingen, Germany). The formed zones were recorded and measured in millimeters by two calibrated observers. The largest ZOI indicated the most potent antibacterial agent against E. faecalis.

Stage 2: assessment of MIC of PS that showed maximum ZOI against E. faecalis

MIC of PS solution
The PS that showed the maximum antibacterial activity against E. faecalis was further assessed for its MIC using descending concentrations from 200 to 3.10 mg/ml diluted using sterile water. The prepared concentrations were tested for their antibacterial activity against E. faecalis using agar well diffusion assay as mentioned above. Two calibrated observers recorded the ZOI and determined the MIC as the least concentration of PS that showed ZOI [20, 21].
MIC of PS gel
The MIC of PS gel that displayed the largest ZOI against E. faecalis was determined using descending concentrations from 200 to 3.10 mg/ml. The anticipated descending concentrations were obtained by adding poloxamer powder 30% to the previously prepared different concentrations of PS solution and kept in the refrigerator overnight. Consequently, the well diffusion assay was performed, and the formed zones were recorded. MIC was obtained and compared with the MIC of PS solution [20, 21].
Assessment of the MIC of PS against E. faecalis by broth microdilution method
The MIC of PS for E. faecalis was also tested using the broth microdilution (BMD) method according to CLSI (Clinical Laboratory Standards Institute) guidelines [46]. Two-fold serial dilutions ranging from 200 to 0.10 mg/ml for PS were performed using cation-adjusted Mueller–Hinton broth (CAMHB). The E. faecalis inoculum was prepared to give a final concentration of 5 × 105 CFU/ml in microtiter plate wells. The results were read for turbidity, MIC was determined as the least concentration of PS cocktail that inhibited visible growth of the organism and compared with the MIC obtained by agar well diffusion assay. In order to define the minimum bactericidal concentration (MBC) activities of the tested PS, the content of the clear wells was thoroughly mixed, and 10 μl were inoculated onto blood agar, incubated at 37 °C for 24 h and examined for 99.9% kill on the next day.

Statistical analysis

Data were analyzed using IBM SPSS for Windows (Version 23.0). Normality was checked for all variables using descriptive statistics, plots (Q-Q plots and histogram), and normality tests. Means and standard deviation (SD) were calculated for all variables. Comparisons of ZOI of different PS supernatants and MIC concentrations in solution and gel were done using the independent samples t-test, while the comparison of ZOI between different supernatants in both solution and gel groups was done using one-way ANOVA test. Comparison of ZOI between Ca(OH)2, PS gel and PS solution groups, and comparisons of MIC of different concentrations in solution and gel groups were done using one-way ANOVA, followed by multiple pairwise comparisons using Bonferroni adjusted significance levels (for significant results). Significance was set at p value < 0.05.

Results

Stage 1. antibacterial activity of PS against E. faecalis

Figure 2 displayed the antibacterial effect of the three PS and the cocktail mix of the three supernatants (Lactobacillus plantarum; LP ATCC 14,917, Lactobacillus rhamnosus; LR ATCC 7469 and Lactobacillus acidophilus; LA ATCC 4356) in solution and gel phases by using agar well diffusion assay. It was observed that all supernatants and cocktail mixes showed growth inhibition of E. faecalis with obvious ZOI in both solution and gel forms.
It is noteworthy to mention that the cocktail mix of the three supernatants (LP, LR, LA) had the highest antibacterial activity as it showed the largest ZOI against E. faecalis in both solution and gel phases, thus was selected for further assessment tests.
Table 1 showed a non-significant difference between each of the three supernatants/cocktail mixes, neither in solution nor in gel phases (p > 0.05).
Table 1
Comparison of ZOI (in millimeters) of PS strains against E. faecalis
Supernatant
Solution
Gel
T- test
p value
(Mean ± SD)
Lactobacillus plantarum (1)
14.00 ± 0.00
13.00 ± 0.00
0.24
Lactobacillus rhamnosus (2)
14.00 ± 1.41
13.50 ± 0.71
0.50
Lactobacillus acidophilus (3)
13.50 ± 0.71
12.00 ± 0.00
0.36
Cocktail mix
14.83 ± 1.60
14.00 ± 1.55
0.43
Control
ND
ND
One-way ANOVA p value
0.34
0.26
 
Data represented are the means of duplicates ± standard error of means
ND Not detected

Antibacterial potentials of PS solution, PS gel and Ca(OH) 2 against E. faecalis

The antibacterial activity of the two experimental groups (PS cocktail solution, PS cocktail gel) and one control: Ca(OH)2 paste was assessed by agar well diffusion assay as shown in Fig. 3.
The largest ZOI indicated the most potent antibacterial effect against E. faecalis, Ca(OH)2 paste was found to be the least potent agent.
There was a significant difference in the antibacterial activity between PS solution, PS gel and calcium hydroxide (35% Ultra Cal XS Ca(OH)2 (p < 0.05), however, there was no significant difference in the antibacterial activity between PS solution and PS gel (p > 0.05) as shown in Table 2.
Table 2
Comparison of ZOI (in millimeters) of PS cocktail solution, PS cocktail gel and Ca(OH)2 paste against E. faecalis
 
PS solution
PS gel
Ca(OH)2 paste
One Way ANOVA
P value
Mean ± SD
14.83 ± 1.60 b
14.00 ± 1.55 b
10.50 ± 0.71 a
0.02*
Data represented are the means of duplicates ± standard error of means
a, b Different letters denote statistically significant differences between groups using Bonferroni adjusted significance levels
*Statistically significant at p value < 0.05

Stage 2. the MIC of the PS against E. faecalis by agar well diffusion assay

The MIC of PS cocktail mix (LP, LR, LA) denoting antibacterial activity was determined by using descending gradient concentrations from 200 to 3.10 mg/ml of the cocktail mix for the solution and gel forms. The MIC was (50 mg/ml) for both gel and solution forms without any significant difference between them (p > 0.05). (Figs. 4 and 5).
Table 3 revealed a significant difference between 300, 100 and 50 mg/ml concentrations, but no difference existed between 300 and 200 mg/ml in both solution and gel forms.
Table 3
MIC of PS cocktail solution and gel against E. faecalis
Concentration
mg/ml
PS solution
PS gel
T-test
p value
ZOI (in millimeters)
Mean ± SD
300
15.50 ± 0.71 a
14.50 ± 0.71 a
0.10
200
14.83 ± 1.60 a
14.00 ± 1.55 a
0.11
100
10.50 ± 0.71 b
8.50 ± 0.71 b
0.38
50
8.50 ± 0.71 b
7.00 ± 0.00 b
0.29
25
ND
ND
12.5
ND
ND
6.5
ND
ND
3.1
ND
ND
One-Way ANOVA
0.001*
 < 0.001*
 
Data represented are the means of duplicates ± standard error of means
ND Not detected
*Statistically significant at p value < 0.05
a,b: Different letters denote statistically significant differences between different concentrations in each group using Bonferroni adjusted significance levels

The MIC of PS cocktail against E. faecalis by broth microdilution method

In Table 4, The MIC of the PS cocktail solution only was determined (50 mg/ml) and was similar to those obtained by agar diffusion assay. The result of the MBC confirmed the result of MIC.
Table 4
The MIC of PS cocktail against E. faecalis by agar well diffusion assay and broth microdilution method
Agar well diffusion assay method
Broth microdilution method
Concentration
(mg/ml)
ZOI
(Y/N)
Concentration
(mg/ml)
Visible growth
(Y/N)
300
Y
300
N
200
Y
200
N
100
Y
100
N
50 (MIC)
Y
50 (MIC)
N
25
N
25
Y
12.50
N
12.50
Y
6.25
N
6.25
Y
3.13
N
3.13
Y
1.50
Y
.80
Y
.40
Y
.20
Y
0.10
Y
*Y: Yes, N: No, MIC was the same for both tests

Discussion

Since persistent bacteria in the root canal system is the main cause of root canal failure, there is an increasing demand to find a potent antibacterial agent against most endodontic pathogens with less toxic effects [1, 2]. Subsequently, this study was conducted to assess the antibacterial effect of Lactobacilli probiotics as a potential endodontic medication in comparison with Ca(OH)2 paste.
The study involved two stages; (stage one): determination of the antibacterial potential of PS in liquid and gel phase against E. faecalis then compare it with Ca(OH)2 paste. This was followed by (stage two): assessment of MIC of the PS that showed the maximum ZOI.
The first stage of the study revealed that the PS cocktail mix is the most potent PS and was more effective than Ca(OH)2. The PS cocktail mix showed the largest ZOI both in solution and gel forms while stage two showed that the MIC of PS cocktail solution and gel were the same without any significant difference between them. Subsequently, the broth microdilution method was done on the PS solution only to confirm the MIC which was found to be similar.
The null hypothesis was rejected as the antibacterial effect of the Lactobacilli cocktail mix of the three supernatants (gel and solution) was significantly higher than the Ca(OH)2 paste.
E. faecalis was selected as an endodontic pathogen example due to its resistance to the high pH of Ca(OH)2 [6, 9]. In addition, it is one of the most frequently isolated bacteria from failed root canal treatments as it has a substantial role in persistent infection and is frequently encountered in primary infections [7, 47].
Calcium hydroxide Ultra Cal XS (Ca(OH)2) is the routinely used medication in root canal treatments, commercially available in the market, but has a limited ability against E. faecalis infection [13, 48]. Therefore, it was selected as a historical control for comparison with the new antibacterial agent.
Recently, probiotics had a growing role in the dental field owing to their antibacterial and anti-inflammatory potential in controlling infectious and inflammatory diseases like gingivitis and periodontitis [17, 27, 28, 49]. Three strains of Lactobacilli probiotics were selected L. plantarum (LP), L. rhamnosus (LR) and L. acidophilus (LA) as being the most commonly used probiotics in dental research [34, 38, 49].
Poloxamer 407 was chosen as a vehicle material for development of PS gel since it was used as an in-situ gel containing antibiotics in treatment of periodontal disease, also used in toothpastes, contraceptive gels and burn dressing materials [4345]. The thermo-reversible properties of poloxamer gel 30% make it an appropriate drug delivery vehicle as it exists in gel form at room temperature and liquid form at low temperature mainly 4 °C [33, 43].
Although the study started with a concentration of 200 mg/ml PS in the first stage, 300 mg/ml was used as a higher concentration to compare the effectiveness of a concentration higher than 200 mg/ml, but it was found not significant. Therefore, this study recommends using another higher concentration like 400 mg/ml or more and comparing its efficiency with the 200 mg/ml concentration.
Agar well diffusion and broth microdilution are valid antimicrobial susceptibility testing methods that are commonly used to detect new antimicrobial agents [50, 51]. One of the drawbacks of the agar diffusion assay is that its result depends on the diffusibility of the tested agents [50], thus it is recommended to use another assessment method like the direct exposure test (DET) and compare its results with the agar diffusion test as Estrela et al. [52] performed in their study.
All PS supernatants showed a variable potential of growth inhibition on E. faecalis with the superiority of the PS cocktail mix indicating a possible synergistic effect of the three strains. These findings were supported by Plaza-Diaz [17], who reviewed the main mechanism of action of probiotics which included prevention of biofilm formation by competitive exclusion of pathogens and production of bacteriocin and other antimicrobial substances.
The results agreed with Seifelnasr’s study [32], which showed that L.rhamnosus L. acidophilus, L. casei had an inhibitory action on E. faecalis and are the most common used probiotics in commercial cocktail. Furthermore, Bohora et al. [33] who used commercial probiotics cocktails (Ecobion and Darolac), stated that probiotics effectively prevented the growth of E. faecalis. Another study held by the same author using individual probiotics strains (L. rhamnosus (ATCC 7469, L. plantarum (ATCC 8014),) and Bifidobacterium bifidum (ATCC 11,863)) showed the same result [34]. On the contrary, Hammad [31] used two strains of Lactobacillus, PTA 5289 and DSM 17,938 and found that probiotics had a non-significant effect on E. faecalis.
On comparing the (PS) cocktail mix (gel and solution) with 35%, Ultra Cal XS Ca(OH)2 paste against E. faecalis, Ca(OH)2 paste exhibited the least ZOI. The possible reason for this result could be due to the limited diffusion of Ca(OH)2 paste through blood agar because of its high viscosity, as the viscosity of the paste can affect the antibacterial activity [11].
However, Ultra Cal XS contains 3% propylene glycol and 2% methylcellulose [53, 54]. Propylene glycol is a viscous vehicle that reduces dispersion and diffusion due to its high molecular weight but maintains prolonged release and improves handling of the material [11, 55]. Methylcellulose is an aqueous stabilizing matrix that allows rapid dissociation of ions and improves the diffusibility and viscosity of the paste [11, 56].
Blanscet et al. [56] used the agar diffusion method to compare the antibacterial effect of Ca(OH)2 paste with different concentrations and vehicles on E. faecalis and found that the effect of 35% Ultra Cal XS Ca(OH)2 paste with aqueous methylcellulose was less than 60- 40% Ca(OH)2 but greater than 30% Vitapex (Neo-Dental Int, Federal Way, WA) with non-aqueous silicone vehicle.
The present study advocated that Lactobacilli PS could be used as an irrigant (liquid form) or an intracanal medication (gel form) as no significant differences were found between PS solution and gel. This study could be considered the baseline for using PS in endodontics as the minimum effective concentration of PS was determined, but further evaluations are needed in future studies.
Similar to the present study, El-Sayed et al. [35] and Kumari [36] et al. revealed that probiotics are potential natural irrigants. In future studies, it is recommended to compare the antibacterial efficacy of PS cocktail solution with the gold standard irrigant (sodium hypochlorite).
Moreover, Noushad et al. [37] reported that probiotics could be a promising intracanal medication that could inhibit E. faecalis more than and Ca(OH)2 but less than triple antibiotic paste.
Regarding limitations of the present study, the study was performed on E. faecalis in the Planktonic state; however, persistent bacteria are present in a biofilm form, which is harder to eradicate. Nevertheless, a tooth model is a more reliable method to assess antibacterial activity as intra-canal agents can be inactivated by dentin [57]. Another limitation, the culture and antimicrobial testing methods (agar diffusion assay and broth microdilution) are highly subjective. Results should have been confirmed by more accurate techniques as time kill assay.
Benbelaïd et al. [47] evaluated the antimicrobial effect of essential oil against E. faecalis in both planktonic and biofilm states and determined biofilm eradication concentration (BEC). Accordingly, it is recommended to assess the BEC of the PS cocktail against E. faecalis and compare it with the MIC.
Future studies can evaluate PS cocktail gel with different vehicles to detect the ideal delivery vehicle of PS for clinical application. This study was the first to use a cocktail mix of three supernatants of PS in gel form and assess its antibacterial activity, besides determining the MIC of the PS against E. faecalis.

Conclusion

Lactobacilli PS cocktail revealed a significant antibacterial effect against E. faecalis, suggesting them as a promising antibacterial agent that can be used as an irrigant or an intracanal medication by using poloxamer 407 as a vehicle.

Acknowledgements

The authors would like to thank Dr. Nourhan M. Aly for the statistical analysis of the present study.

Declarations

Ethical approval of this invitro study was obtained from the Research Ethics Committee, Faculty of Dentistry, Alexandria University, Egypt (IRB 00010556 – IORG 0008839).
Not applicable.

Competing interests

The authors declared no competing of interests in this study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Rocas IN, Siqueira JF Jr. Identification of bacteria enduring endodontic treatment procedures by a combined reverse transcriptase-polymerase chain reaction and reverse-capture checkerboard approach. J Endod. 2010;36(1):45–52.PubMedCrossRef Rocas IN, Siqueira JF Jr. Identification of bacteria enduring endodontic treatment procedures by a combined reverse transcriptase-polymerase chain reaction and reverse-capture checkerboard approach. J Endod. 2010;36(1):45–52.PubMedCrossRef
2.
Zurück zum Zitat Love RM. Invasion of dentinal tubules by root canal bacteria. Endod Top. 2004;9(1):52–65.CrossRef Love RM. Invasion of dentinal tubules by root canal bacteria. Endod Top. 2004;9(1):52–65.CrossRef
3.
Zurück zum Zitat Hancock HH 3rd, Sigurdsson A, Trope M, Moiseiwitsch J. Bacteria isolated after unsuccessful endodontic treatment in a North American population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(5):579–86.PubMedCrossRef Hancock HH 3rd, Sigurdsson A, Trope M, Moiseiwitsch J. Bacteria isolated after unsuccessful endodontic treatment in a North American population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(5):579–86.PubMedCrossRef
4.
Zurück zum Zitat Waltimo T, Trope M, Haapasalo M, Orstavik D. Clinical efficacy of treatment procedures in endodontic infection control and one year follow-up of periapical healing. J Endod. 2005;31(12):863–6.PubMedCrossRef Waltimo T, Trope M, Haapasalo M, Orstavik D. Clinical efficacy of treatment procedures in endodontic infection control and one year follow-up of periapical healing. J Endod. 2005;31(12):863–6.PubMedCrossRef
5.
Zurück zum Zitat Peters LB, Wesselink PR, Moorer WR. The fate and the role of bacteria left in root dentinal tubules. Int Endod J. 1995;28(2):95–9.PubMedCrossRef Peters LB, Wesselink PR, Moorer WR. The fate and the role of bacteria left in root dentinal tubules. Int Endod J. 1995;28(2):95–9.PubMedCrossRef
6.
Zurück zum Zitat Zhang C, Du J, Peng Z. Correlation between enterococcus faecalis and persistent intraradicular infection compared with primary intraradicular infection: a systematic review. J Endod. 2015;41(8):1207–13.PubMedCrossRef Zhang C, Du J, Peng Z. Correlation between enterococcus faecalis and persistent intraradicular infection compared with primary intraradicular infection: a systematic review. J Endod. 2015;41(8):1207–13.PubMedCrossRef
7.
Zurück zum Zitat Vivacqua-Gomes N, Gurgel-Filho ED, Gomes BP, Ferraz CC, Zaia AA, Souza-Filho FJ. Recovery of Enterococcus faecalis after single- or multiple-visit root canal treatments carried out in infected teeth ex vivo. Int Endod J. 2005;38(10):697–704.PubMedCrossRef Vivacqua-Gomes N, Gurgel-Filho ED, Gomes BP, Ferraz CC, Zaia AA, Souza-Filho FJ. Recovery of Enterococcus faecalis after single- or multiple-visit root canal treatments carried out in infected teeth ex vivo. Int Endod J. 2005;38(10):697–704.PubMedCrossRef
8.
Zurück zum Zitat Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod. 2006;32(2):93–8.PubMedCrossRef Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod. 2006;32(2):93–8.PubMedCrossRef
9.
Zurück zum Zitat Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endod J. 2002;35(3):221–8.PubMedCrossRef Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endod J. 2002;35(3):221–8.PubMedCrossRef
10.
Zurück zum Zitat Du T, Wang Z, Shen Y, Ma J, Cao Y, Haapasalo M. Effect of long-term exposure to endodontic disinfecting solutions on young and old Enterococcus faecalis biofilms in dentin canals. J Endod. 2014;40(4):509–14.PubMedCrossRef Du T, Wang Z, Shen Y, Ma J, Cao Y, Haapasalo M. Effect of long-term exposure to endodontic disinfecting solutions on young and old Enterococcus faecalis biofilms in dentin canals. J Endod. 2014;40(4):509–14.PubMedCrossRef
11.
Zurück zum Zitat Mohammadi Z, Dummer PM. Properties and applications of calcium hydroxide in endodontics and dental traumatology. Int Endod J. 2011;44(8):697–730.PubMedCrossRef Mohammadi Z, Dummer PM. Properties and applications of calcium hydroxide in endodontics and dental traumatology. Int Endod J. 2011;44(8):697–730.PubMedCrossRef
12.
Zurück zum Zitat Siqueira JF Jr, Lopes HP. Mechanisms of antimicrobial activity of calcium hydroxide: a critical review. Int Endod J. 1999;32(5):361–9.PubMedCrossRef Siqueira JF Jr, Lopes HP. Mechanisms of antimicrobial activity of calcium hydroxide: a critical review. Int Endod J. 1999;32(5):361–9.PubMedCrossRef
13.
Zurück zum Zitat Kim D, Kim E. Antimicrobial effect of calcium hydroxide as an intracanal medicament in root canal treatment: a literature review - Part II. in vivo studies. Restor Dent Endod. 2015;40(2):97–103.PubMedCrossRef Kim D, Kim E. Antimicrobial effect of calcium hydroxide as an intracanal medicament in root canal treatment: a literature review - Part II. in vivo studies. Restor Dent Endod. 2015;40(2):97–103.PubMedCrossRef
14.
Zurück zum Zitat Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl 2):S108-21.PubMedPubMedCentralCrossRef Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl 2):S108-21.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: a review. J Food Drug Anal. 2018;26(3):927–39.CrossRef George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: a review. J Food Drug Anal. 2018;26(3):927–39.CrossRef
18.
Zurück zum Zitat Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257(1):78–92.PubMedCrossRef Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257(1):78–92.PubMedCrossRef
19.
Zurück zum Zitat Khoder G, Al-Menhali AA, Al-Yassir F, Karam SM. Potential role of probiotics in the management of gastric ulcer. Exp Ther Med. 2016;12(1):3–17.PubMedPubMedCentralCrossRef Khoder G, Al-Menhali AA, Al-Yassir F, Karam SM. Potential role of probiotics in the management of gastric ulcer. Exp Ther Med. 2016;12(1):3–17.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Hamad G, Abu-Serie M, Ali S, Hafez E. Combination probiotic supernatants reduce growth and aflatoxin production by Aspergillus spp in food contamination. Am J Food Sci Tech. 2018;6:57–67. Hamad G, Abu-Serie M, Ali S, Hafez E. Combination probiotic supernatants reduce growth and aflatoxin production by Aspergillus spp in food contamination. Am J Food Sci Tech. 2018;6:57–67.
21.
Zurück zum Zitat Hamad GM, Abdelmotilib NM, Darwish AMG, Zeitoun AM. Commercial probiotic cell-free supernatants for inhibition of Clostridium perfringens poultry meat infection in Egypt. Anaerobe. 2020;62:102181.PubMedCrossRef Hamad GM, Abdelmotilib NM, Darwish AMG, Zeitoun AM. Commercial probiotic cell-free supernatants for inhibition of Clostridium perfringens poultry meat infection in Egypt. Anaerobe. 2020;62:102181.PubMedCrossRef
22.
Zurück zum Zitat Menon A. Implications of probiotics on oral health: past-to-present. J Dent Res Rev. 2016;3(1):36.CrossRef Menon A. Implications of probiotics on oral health: past-to-present. J Dent Res Rev. 2016;3(1):36.CrossRef
23.
Zurück zum Zitat Cannon ML, Vorachek A, Le C, White K. Retrospective review of oral probiotic therapy. J Clin Pediatr Dent. 2019;43(6):367–71.PubMedCrossRef Cannon ML, Vorachek A, Le C, White K. Retrospective review of oral probiotic therapy. J Clin Pediatr Dent. 2019;43(6):367–71.PubMedCrossRef
24.
Zurück zum Zitat Hu X, Huang Z, Zhang Y, Hong Y, Zheng Y. Effects of a probiotic drink containing Lactobacillus casei strain Shirota on dental plaque microbiota. J Int Med Res. 2019;47(7):3190–202.PubMedPubMedCentralCrossRef Hu X, Huang Z, Zhang Y, Hong Y, Zheng Y. Effects of a probiotic drink containing Lactobacillus casei strain Shirota on dental plaque microbiota. J Int Med Res. 2019;47(7):3190–202.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. 2006;100(4):754–64.PubMedCrossRef Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. 2006;100(4):754–64.PubMedCrossRef
26.
Zurück zum Zitat Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, et al. Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. J Dent Res. 2007;86(2):125–30.PubMedCrossRef Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, et al. Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. J Dent Res. 2007;86(2):125–30.PubMedCrossRef
27.
Zurück zum Zitat Akram Z, Shafqat SS, Aati S, Kujan O, Fawzy A. Clinical efficacy of probiotics in the treatment of gingivitis: a systematic review and meta-analysis. Aust Dent J. 2020;65(1):12–20.PubMedCrossRef Akram Z, Shafqat SS, Aati S, Kujan O, Fawzy A. Clinical efficacy of probiotics in the treatment of gingivitis: a systematic review and meta-analysis. Aust Dent J. 2020;65(1):12–20.PubMedCrossRef
28.
Zurück zum Zitat Martin-Cabezas R, Davideau JL, Tenenbaum H, Huck O. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016;43(6):520–30.PubMedCrossRef Martin-Cabezas R, Davideau JL, Tenenbaum H, Huck O. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016;43(6):520–30.PubMedCrossRef
29.
Zurück zum Zitat Gatej S, Gully N, Gibson R, Bartold PM. Probiotics and periodontitis - a literature review. J Int Acad Periodontol. 2017;19(2):42–50.PubMed Gatej S, Gully N, Gibson R, Bartold PM. Probiotics and periodontitis - a literature review. J Int Acad Periodontol. 2017;19(2):42–50.PubMed
30.
Zurück zum Zitat Bohora A, Kokate S. Concept of probiotics in endodontics. Int J Adv Res. 2016;4:1137–42.CrossRef Bohora A, Kokate S. Concept of probiotics in endodontics. Int J Adv Res. 2016;4:1137–42.CrossRef
33.
Zurück zum Zitat Bohora A, Kokate S. Evaluation of the role of probiotics in endodontic treatment: a preliminary study. J Int Soc Prev Commun Dent. 2017;7(1):46–51.CrossRef Bohora A, Kokate S. Evaluation of the role of probiotics in endodontic treatment: a preliminary study. J Int Soc Prev Commun Dent. 2017;7(1):46–51.CrossRef
34.
Zurück zum Zitat Bohora AA, Kokate SR, Khedkar S, Vankudre A. Antimicrobial activity of probiotics against endodontic pathogens:- a preliminary study. Indian J Med Microbiol. 2019;37(1):5–11.PubMedCrossRef Bohora AA, Kokate SR, Khedkar S, Vankudre A. Antimicrobial activity of probiotics against endodontic pathogens:- a preliminary study. Indian J Med Microbiol. 2019;37(1):5–11.PubMedCrossRef
35.
36.
Zurück zum Zitat Kumari M, Kochhar R, Rai P. Antimicrobial activity of three different Probiotic strains and 5.25% Sodium hypochlorite against E.faecalis and C.albicans at two different time period: an in-vitro study. Int J Sci Res Publ (IJSRP). 2019;9(4):8879. Kumari M, Kochhar R, Rai P. Antimicrobial activity of three different Probiotic strains and 5.25% Sodium hypochlorite against E.faecalis and C.albicans at two different time period: an in-vitro study. Int J Sci Res Publ (IJSRP). 2019;9(4):8879.
38.
Zurück zum Zitat Cosme-Silva L, Dal-Fabbro R, Cintra LTA, Ervolino E, Plazza F, Mogami Bomfim S, et al. Reduced bone resorption and inflammation in apical periodontitis evoked by dietary supplementation with probiotics in rats. Int Endod J. 2020;53(8):1084–92.PubMedCrossRef Cosme-Silva L, Dal-Fabbro R, Cintra LTA, Ervolino E, Plazza F, Mogami Bomfim S, et al. Reduced bone resorption and inflammation in apical periodontitis evoked by dietary supplementation with probiotics in rats. Int Endod J. 2020;53(8):1084–92.PubMedCrossRef
39.
Zurück zum Zitat Cosme-Silva L, Dal-Fabbro R, Cintra LTA, Dos Santos VR, Duque C, Ervolino E, et al. Systemic administration of probiotics reduces the severity of apical periodontitis. Int Endod J. 2019;52(12):1738–49.PubMedCrossRef Cosme-Silva L, Dal-Fabbro R, Cintra LTA, Dos Santos VR, Duque C, Ervolino E, et al. Systemic administration of probiotics reduces the severity of apical periodontitis. Int Endod J. 2019;52(12):1738–49.PubMedCrossRef
40.
Zurück zum Zitat Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh Jahromi M, et al. Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains. Biomed Res Int. 2014;2014:927268.PubMedPubMedCentralCrossRef Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh Jahromi M, et al. Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains. Biomed Res Int. 2014;2014:927268.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Barzegari A, Kheyrolahzadeh K, Hosseiniyan Khatibi SM, Sharifi S, Memar MY, Zununi VS. The battle of probiotics and their derivatives against biofilms. Infect Drug Resist. 2020;13:659–72.PubMedPubMedCentralCrossRef Barzegari A, Kheyrolahzadeh K, Hosseiniyan Khatibi SM, Sharifi S, Memar MY, Zununi VS. The battle of probiotics and their derivatives against biofilms. Infect Drug Resist. 2020;13:659–72.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Nagendrababu V, Murray PE, Ordinola-Zapata R, Peters OA, Rocas IN, Siqueira JF Jr, et al. PRILE 2021 guidelines for reporting laboratory studies in endodontology: a consensus-based development. Int Endod J. 2021;54(9):1482–90.PubMedCrossRef Nagendrababu V, Murray PE, Ordinola-Zapata R, Peters OA, Rocas IN, Siqueira JF Jr, et al. PRILE 2021 guidelines for reporting laboratory studies in endodontology: a consensus-based development. Int Endod J. 2021;54(9):1482–90.PubMedCrossRef
43.
Zurück zum Zitat Patel HR, Patel RP, Patel M. Poloxamers: a pharmaceutical excipients with therapeutic behaviors. Int J PharmTech Res. 2009;1:299–303. Patel HR, Patel RP, Patel M. Poloxamers: a pharmaceutical excipients with therapeutic behaviors. Int J PharmTech Res. 2009;1:299–303.
44.
Zurück zum Zitat Bansal M, Mittal N, Yadav SK, Khan G, Gupta P, Mishra B, et al. Periodontal thermoresponsive, mucoadhesive dual antimicrobial loaded in-situ gel for the treatment of periodontal disease: preparation, in-vitro characterization and antimicrobial study. J Oral Biol Craniofac Res. 2018;8(2):126–33.PubMedCrossRef Bansal M, Mittal N, Yadav SK, Khan G, Gupta P, Mishra B, et al. Periodontal thermoresponsive, mucoadhesive dual antimicrobial loaded in-situ gel for the treatment of periodontal disease: preparation, in-vitro characterization and antimicrobial study. J Oral Biol Craniofac Res. 2018;8(2):126–33.PubMedCrossRef
45.
Zurück zum Zitat Esposito E, Carotta V, Scabbia A, Trombelli L, D’Antona P, Menegatti E, et al. Comparative analysis of tetracycline-containing dental gels: Poloxamer- and monoglyceride-based formulations. Int J Pharm. 1996;142(1):9–23.CrossRef Esposito E, Carotta V, Scabbia A, Trombelli L, D’Antona P, Menegatti E, et al. Comparative analysis of tetracycline-containing dental gels: Poloxamer- and monoglyceride-based formulations. Int J Pharm. 1996;142(1):9–23.CrossRef
46.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests f or bacteria that grow aerobically; Approved Standard—Ninth Edition. CLSI document M07-A9. Wayne: Clinical and Laboratory Standards Institute. 2012. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests f or bacteria that grow aerobically; Approved Standard—Ninth Edition. CLSI document M07-A9. Wayne: Clinical and Laboratory Standards Institute. 2012.
47.
Zurück zum Zitat Benbelaïd F, Khadir A, Abdoune MA, Bendahou M, Muselli A, Costa J. Antimicrobial activity of some essential oils against oral multidrug-resistant Enterococcus faecalis in both planktonic and biofilm state. Asian Pac J Trop Biomed. 2014;4(6):463–72.PubMedPubMedCentralCrossRef Benbelaïd F, Khadir A, Abdoune MA, Bendahou M, Muselli A, Costa J. Antimicrobial activity of some essential oils against oral multidrug-resistant Enterococcus faecalis in both planktonic and biofilm state. Asian Pac J Trop Biomed. 2014;4(6):463–72.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Asnaashari M, Eghbal MJ, Sahba Yaghmayi A, Shokri M, Azari-Marhabi S. Comparison of antibacterial effects of photodynamic therapy, modified triple antibiotic paste and calcium hydroxide on root canals infected with enterococcus faecalis: an in vitro study. J Lasers Med Sci. 2019;10(Suppl 1):S23–9.PubMedPubMedCentralCrossRef Asnaashari M, Eghbal MJ, Sahba Yaghmayi A, Shokri M, Azari-Marhabi S. Comparison of antibacterial effects of photodynamic therapy, modified triple antibiotic paste and calcium hydroxide on root canals infected with enterococcus faecalis: an in vitro study. J Lasers Med Sci. 2019;10(Suppl 1):S23–9.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Kumar G, Tewari S, Tagg J, Chikindas ML, Popov IV, Tiwari SK. Can probiotics emerge as effective therapeutic agents in apical periodontitis? a review. Probiotics Antimicrob Proteins. 2021;13(2):299–314.PubMedCrossRef Kumar G, Tewari S, Tagg J, Chikindas ML, Popov IV, Tiwari SK. Can probiotics emerge as effective therapeutic agents in apical periodontitis? a review. Probiotics Antimicrob Proteins. 2021;13(2):299–314.PubMedCrossRef
50.
Zurück zum Zitat Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71–9.PubMedCrossRef Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71–9.PubMedCrossRef
51.
Zurück zum Zitat Nalawade TM, Bhat KG, Sogi S. Antimicrobial activity of endodontic medicaments and vehicles using agar well diffusion method on facultative and obligate anaerobes. Int J Clin Pediatr Dent. 2016;9(4):335–41.PubMedPubMedCentralCrossRef Nalawade TM, Bhat KG, Sogi S. Antimicrobial activity of endodontic medicaments and vehicles using agar well diffusion method on facultative and obligate anaerobes. Int J Clin Pediatr Dent. 2016;9(4):335–41.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Estrela C, de Araujo Estrela CR, Bammann LL, Pecora JD. Two methods to evaluate the antimicrobial action of calcium hydroxide paste. J Endod. 2001;27(12):720–3.PubMedCrossRef Estrela C, de Araujo Estrela CR, Bammann LL, Pecora JD. Two methods to evaluate the antimicrobial action of calcium hydroxide paste. J Endod. 2001;27(12):720–3.PubMedCrossRef
53.
Zurück zum Zitat Caicedo R, Mercante DE, Alongi DJ. Calcium-ion diffusion of four calcium-hydroxide-based materials : ultracal XS, vitapex, roeko calcium-hydroxide plus points, and pure calcium hydroxide through radicular dentin. Int J Oral-Med Sci. 2004;3(2):75–82.CrossRef Caicedo R, Mercante DE, Alongi DJ. Calcium-ion diffusion of four calcium-hydroxide-based materials : ultracal XS, vitapex, roeko calcium-hydroxide plus points, and pure calcium hydroxide through radicular dentin. Int J Oral-Med Sci. 2004;3(2):75–82.CrossRef
54.
Zurück zum Zitat Guedes OA, Henrique TL, Pollyana Sousa L, et al. Endodontic management of a tooth with severe external root resorption using injected non-setting calcium hydroxide paste: a case report. J Clin Diagn Res. 2020;14(7):ZD01–4. Guedes OA, Henrique TL, Pollyana Sousa L, et al. Endodontic management of a tooth with severe external root resorption using injected non-setting calcium hydroxide paste: a case report. J Clin Diagn Res. 2020;14(7):ZD01–4.
55.
Zurück zum Zitat Grover C, Shetty N. Evaluation of calcium ion release and change in pH on combining calcium hydroxide with different vehicles. Contemp Clin Dent. 2014;5(4):434–9.PubMedPubMedCentralCrossRef Grover C, Shetty N. Evaluation of calcium ion release and change in pH on combining calcium hydroxide with different vehicles. Contemp Clin Dent. 2014;5(4):434–9.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Blanscet ML, Tordik PA, Goodell GG. An agar diffusion comparison of the antimicrobial effect of calcium hydroxide at five different concentrations with three different vehicles. J Endod. 2008;34(10):1246–8.PubMedCrossRef Blanscet ML, Tordik PA, Goodell GG. An agar diffusion comparison of the antimicrobial effect of calcium hydroxide at five different concentrations with three different vehicles. J Endod. 2008;34(10):1246–8.PubMedCrossRef
57.
Zurück zum Zitat Haapasalo HK, Sirén EK, Waltimo TM, Ørstavik D, Haapasalo MP. Inactivation of local root canal medicaments by dentine: an in vitro study. Int Endod J. 2000;33(2):126–31.PubMedCrossRef Haapasalo HK, Sirén EK, Waltimo TM, Ørstavik D, Haapasalo MP. Inactivation of local root canal medicaments by dentine: an in vitro study. Int Endod J. 2000;33(2):126–31.PubMedCrossRef
Metadaten
Titel
Evaluation of the antibacterial activity of Lactobacilli probiotics supernatants against Enterococcus faecalis (in-vitro study)
verfasst von
Shymaa Shaaban
Gamal M. Hamad
Salma Genena
Marwa A. Meheissen
Sybel Moussa
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Oral Health / Ausgabe 1/2022
Elektronische ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-022-02434-5

Weitere Artikel der Ausgabe 1/2022

BMC Oral Health 1/2022 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.